Related pages

Identifying and Managing Adverse Events Associated with Immune Checkpoint Inhibitors
GENERAL CONSIDERATIONS
BEFORE BEGINNING THERAPY
- Patient Counseling Recommendations
- Pre-therapy Assessments
imAEs
OTHER TOPICS
- Immunotherapy Rechallenge

BEFORE BEGINNING THERAPY

Privacy Policy
Terms of Use
Contact Us
Sitemap
Accessibility

MSD Egypt, 67 - El Tesseen St., Address Building, Fifth Settlement, New Cairo.

In case you need any updates or you have an inquiry or need to report on an adverse reaction, you can contact: Tel.: +2 02 2614 5100 Mail: DPOC_EGYPT@MSD.COM

This website is maintained by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and is intended for use by individuals who are not residents of the U.S.